Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107298684A reveals efficient intramolecular cyclization. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity spiroindolinones.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.
Patent CN102924360A reveals efficient asymmetric hydrogenation for chiral indolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel AlCl3-catalyzed cyclization route for fungicide intermediates. Offers simplified purification and scalable production for agricultural chemical manufacturers.
Patent CN110343087B details a cobalt-catalyzed C-H activation method for isoindolinone derivatives, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN114507177B reveals a base-promoted synthesis route for isoindolinone intermediates using carbon dioxide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed thiocarbonylation route for indolinone thioesters. Enhanced purity, scalable process, cost-effective sulfonyl chloride sulfur source.
Novel MOF-Cu catalyzed Ugi reaction for high-purity dipeptide intermediates. Cost-effective, scalable synthesis with reusable catalyst for pharmaceutical applications.
Patent CN114057625A details a green electrochemical route for C2-acyloxy-3-indolinone derivatives, offering metal-free synthesis and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN109232529A reveals mild Rh(III) catalysis for nitrogen heterocycles. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Patent CN102911109A reveals a scalable 4-step route for 6-amino-5-fluoro-1-isoindolinone, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN115197199A details a high-yield palladium-catalyzed method for chiral indolinone arylamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115057808A reveals a green Rh-catalyzed method for Z-isoindolinones. High stereoselectivity, no oxidants. Ideal for pharma intermediates supply.
Novel Ni-catalyzed route for sulfur-containing isoindolinones offers high yield and green oxidation for reliable pharmaceutical intermediate supply chains and cost reduction.
Patent CN108707101B details a metal-free photocatalytic route to 3-formyl-2-indolinones. Offers mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Novel TEMPO-mediated hydroxylation patent CN107686460A offers cost-effective pharmaceutical intermediate manufacturing with scalable room temperature processes.
Patent CN113620859A discloses a transition-metal-free route for indeno-indole ketones. This method reduces purification costs and ensures high purity for API intermediates.
Novel one-pot synthesis reduces costs and improves yield for high-purity pharmaceutical intermediates. Environmentally friendly process ensures supply chain reliability.